Cargando…

Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells

Histone demethylase KDM7A regulates many biological processes, including differentiation, development, and the growth of several cancer cells. Here, we have focused on the role of KDM7A in bladder cancer cells, especially under drug-resistant conditions. When the KDM7A gene was knocked down, bladder...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kyoung-Hwa, Kim, Byung-Chan, Jeong, Seung-Hwan, Jeong, Chang Wook, Ku, Ja Hyeon, Kim, Hyeon Hoe, Kwak, Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460860/ https://www.ncbi.nlm.nih.gov/pubmed/32781788 http://dx.doi.org/10.3390/ijms21165658

Ejemplares similares

Histone Demethylase LSD1 Regulates Kidney Cancer Progression by Modulating Androgen Receptor Activity
por: Lee, Kyoung-Hwa, et al.
Publicado: (2020)

MLL5, a histone modifying enzyme, regulates androgen receptor activity in prostate cancer cells by recruiting co-regulators, HCF1 and SET1
por: Lee, Kyoung-Hwa, et al.
Publicado: (2020)

Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells
por: Kang, Minyong, et al.
Publicado: (2017)

Histone lysine demethylase KDM4B regulates the alternative splicing of the androgen receptor in response to androgen deprivation
por: Duan, Lingling, et al.
Publicado: (2019)

The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells
por: Wilson, Stephen, et al.
Publicado: (2017)

Epigenetic regulation of TGF-β-induced EMT by JMJD3/KDM6B histone H3K27 demethylase
por: Lee, Su-Hyun, et al.
Publicado: (2021)

The Histone Demethylase KDM5 Is Essential for Larval Growth in Drosophila
por: Drelon, Coralie, et al.
Publicado: (2018)

The nuclear bodies formed by histone demethylase KDM7A
por: Ming, Hui, et al.
Publicado: (2020)

ETS transcription factor ERG cooperates with histone demethylase KDM4A
por: KIM, TAE-DONG, et al.
Publicado: (2016)

Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis
por: Yoo, Jung, et al.
Publicado: (2022)

Transcriptional repression of ANGPT1 by histone H3K9 demethylase KDM3B
por: Han, Arim, et al.
Publicado: (2015)

Advances in Histone Demethylase KDM3A as a Cancer Therapeutic Target
por: Yoo, Jung, et al.
Publicado: (2020)

Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study
por: Kim, Myong, et al.
Publicado: (2015)

Benzo[b]tellurophenes as a Potential Histone H3 Lysine 9 Demethylase (KDM4) Inhibitor
por: Kim, Yoon-Jung, et al.
Publicado: (2019)

The histone demethylase Kdm3a is essential to progression through differentiation
por: Herzog, Marielle, et al.
Publicado: (2012)

Substrate- and Cofactor-independent Inhibition of Histone Demethylase KDM4C
por: Leurs, Ulrike, et al.
Publicado: (2014)

Histone demethylase KDM5A promotes tumorigenesis of osteosarcoma tumor
por: Peng, Daohu, et al.
Publicado: (2021)

Female Bias in Rhox6 and 9 Regulation by the Histone Demethylase KDM6A
por: Berletch, Joel B., et al.
Publicado: (2013)

Inhibition of Autophagy Potentiates Atorvastatin-Induced Apoptotic Cell Death in Human Bladder Cancer Cells in Vitro
por: Kang, Minyong, et al.
Publicado: (2014)

Survival Outcomes and Predictive Factors for Female Urethral Cancer: Long-term Experience with Korean Patients
por: Kang, Minyong, et al.
Publicado: (2015)

The Characteristics of Recurrent Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy without Bladder Cuff Excision
por: Kang, Minyong, et al.
Publicado: (2015)

Single, immediate postoperative instillation of chemotherapy in non-muscle invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials using different drugs
por: Kang, Minyong, et al.
Publicado: (2016)

Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis
por: Ko, Kyungtae, et al.
Publicado: (2017)

Effects of Aspirin, Nonsteroidal Anti-inflammatory Drugs, Statin, and COX2 Inhibitor on the Developments of Urological Malignancies: A Population-Based Study with 10-Year Follow-up Data in Korea
por: Kang, Minyong, et al.
Publicado: (2018)

Comparing the clinical efficacy of abiraterone acetate, enzalutamide, and orteronel in patients with metastatic castration-resistant prostate cancer by performing a network meta-analysis of eight randomized controlled trials
por: Kang, Minyong, et al.
Publicado: (2017)

Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor
por: Kang, Minyong, et al.
Publicado: (2016)

Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder: External Evaluation and Validation in a Cohort of Korean Patients
por: Kim, Hyung Suk, et al.
Publicado: (2015)

Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials
por: Kim, Hyung Suk, et al.
Publicado: (2017)

Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis
por: Kim, Hyung Suk, et al.
Publicado: (2016)

The histone demethylase LSD1/KDM1A promotes the DNA damage response
por: Mosammaparast, Nima, et al.
Publicado: (2013)

Should intravesical Bacillus Calmette–Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
por: Yuk, Hyeong Dong, et al.
Publicado: (2018)

Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Lymphovascular invasion have a similar prognostic value as lymph node involvement in patients undergoing radical cystectomy with urothelial carcinoma
por: Yuk, Hyeong Dong, et al.
Publicado: (2018)

De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Survival benefit of neoadjuvant chemotherapy in pathologic T2N0 or lower urothelial carcinoma patients: evidence to support the use of neoadjuvant chemotherapy
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Does reduced E-cadherin expression correlate with poor prognosis in patients with upper tract urothelial cell carcinoma?: A systematic review and meta-analysis
por: Tae, Bum Sik, et al.
Publicado: (2019)

Targeting Histone Demethylase LSD1/KDM1a in Neurodegenerative Diseases
por: Ambrosio, Susanna, et al.
Publicado: (2018)

Human histone demethylase KDM6B can catalyse sequential oxidations
por: Hopkinson, Richard J., et al.
Publicado: (2018)

KDM5 histone demethylases repress immune response via suppression of STING
por: Wu, Lizhen, et al.
Publicado: (2018)

Molecular architecture of the Jumonji C family histone demethylase KDM5B
por: Dorosz, Jerzy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f6jh9u1j54ht6reb37eob6c07p